{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:22:14Z","timestamp":1781104934659,"version":"3.54.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","journals.elsevierhealth.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.eururo.2014.04.027","type":"journal-article","created":{"date-parts":[[2014,5,22]],"date-time":"2014-05-22T07:15:41Z","timestamp":1400742941000},"page":"1012-1020","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":118,"title":["Metformin Use and Prostate Cancer Risk"],"prefix":"10.1016","volume":"66","author":[{"given":"Mark A.","family":"Preston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders H.","family":"Riis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Ehrenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney H.","family":"Breau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie L.","family":"Batista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aria F.","family":"Olumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorelei A.","family":"Mucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Olov","family":"Adami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik T.","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2014.04.027_bib0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.eururo.2014.04.027_bib0010","unstructured":"SEER Cancer Statistics Review, 1975\u20132008. Bethesda, MD: National Cancer Institute; 2011."},{"key":"10.1016\/j.eururo.2014.04.027_bib0015","doi-asserted-by":"crossref","first-page":"e1000197","DOI":"10.1371\/journal.pmed.1000197","article-title":"Immediate risk for cardiovascular events and suicide following a prostate cancer diagnosis: prospective cohort study","volume":"6","author":"Fall","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.eururo.2014.04.027_bib0020","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/jnci\/djp537","article-title":"Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis: cohort study in the United States","volume":"102","author":"Fang","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.eururo.2014.04.027_bib0025","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.eururo.2013.02.025","article-title":"Long-term distress after radical prostatectomy versus watchful waiting in prostate cancer: a longitudinal study from the Scandinavian Prostate Cancer Group-4 Randomized Clinical Trial","volume":"64","author":"Bill-Axelson","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2014.04.027_bib0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/00365599.2010.545075","article-title":"Managing localized prostate cancer by radical prostatectomy or watchful waiting: cost analysis of a randomized trial (SPCG-4)","volume":"45","author":"Andersson","year":"2011","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.eururo.2014.04.027_bib0035","doi-asserted-by":"crossref","first-page":"s836","DOI":"10.1093\/ajcn\/86.3.836S","article-title":"Metabolic syndrome, hyperinsulinemia, and colon cancer: a review","volume":"86","author":"Giovannucci","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.eururo.2014.04.027_bib0040","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/jnci\/95.1.67","article-title":"Insulin resistance and prostate cancer risk","volume":"95","author":"Hsing","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.eururo.2014.04.027_bib0045","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1200\/JCO.2004.04.181","article-title":"Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group","volume":"22","author":"Freedland","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2014.04.027_bib0050","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1158\/1055-9965.EPI-06-0477","article-title":"Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial","volume":"15","author":"Gong","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.eururo.2014.04.027_bib0055","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1093\/jnci\/djm231","article-title":"Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts","volume":"99","author":"Venkateswaran","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.eururo.2014.04.027_bib0060","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/ijc.24044","article-title":"Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study","volume":"124","author":"Kasper","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.eururo.2014.04.027_bib0065","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00125-004-1415-6","article-title":"Diabetes mellitus and risk of prostate cancer: a meta-analysis","volume":"47","author":"Bonovas","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.eururo.2014.04.027_bib0070","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1001\/archinte.168.19.2088","article-title":"National trends in treatment of type 2 diabetes mellitus, 1994\u20132007","volume":"168","author":"Alexander","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.eururo.2014.04.027_bib0075","first-page":"89","article-title":"Metformin: a review of its metabolic effects","volume":"6","author":"Cusi","year":"1998","journal-title":"Diabetes Rev"},{"key":"10.1016\/j.eururo.2014.04.027_bib0080","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1158\/1940-6207.CAPR-08-0081","article-title":"The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase","volume":"1","author":"Zakikhani","year":"2008","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.eururo.2014.04.027_bib0085","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1093\/carcin\/bgt307","article-title":"Metformin targets c-MYC oncogene to prevent prostate cancer","volume":"34","author":"Akinyeke","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.eururo.2014.04.027_bib0090","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s10552-009-9407-y","article-title":"Metformin use and prostate cancer in Caucasian men: results from a population-based case-control study","volume":"20","author":"Wright","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.eururo.2014.04.027_bib0095","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1158\/1055-9965.EPI-10-0940","article-title":"Metformin and the incidence of prostate cancer in patients with type 2 diabetes","volume":"20","author":"Azoulay","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.eururo.2014.04.027_bib0100","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1158\/1940-6207.CAPR-10-0157","article-title":"Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis","volume":"3","author":"Decensi","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.eururo.2014.04.027_bib0105","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/aje\/kwn190","article-title":"Antidiabetic medication and prostate cancer risk: a population-based case-control study","volume":"168","author":"Murtola","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.eururo.2014.04.027_bib0110","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/jnci\/djt170","article-title":"Association between metformin use and risk of prostate cancer and its grade","volume":"105","author":"Margel","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.eururo.2014.04.027_bib0115","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1200\/JCO.2012.46.7043","article-title":"Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes","volume":"3","author":"Margel","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2014.04.027_bib0120","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1158\/1055-9965.EPI-12-1046","article-title":"Diabetes mellitus and prostate cancer risk; a nationwide case-control study within PCBaSe Sweden","volume":"22","author":"Fall","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.eururo.2014.04.027_bib0125","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2147\/CLEP.S13458","article-title":"Existing data sources for clinical epidemiology: Aarhus University Prescription Database","volume":"2","author":"Ehrenstein","year":"2010","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.eururo.2014.04.027_bib0130","first-page":"441","article-title":"The Danish Civil Registration System: a cohort of eight million persons","volume":"53","author":"Pedersen","year":"2006","journal-title":"Dan Med Bull"},{"key":"10.1016\/j.eururo.2014.04.027_bib0135","first-page":"445","article-title":"The Danish prescription registries","volume":"44","author":"Gaist","year":"1997","journal-title":"Dan Med Bull"},{"key":"10.1016\/j.eururo.2014.04.027_bib0140","first-page":"535","article-title":"The Danish Cancer Registry\u2014history, content, quality and use","volume":"44","author":"Storm","year":"1997","journal-title":"Dan Med Bull"},{"key":"10.1016\/j.eururo.2014.04.027_bib0145","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1126\/science.287.5462.2398","article-title":"Epidemiology: when an entire country is a cohort","volume":"287","author":"Frank","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.eururo.2014.04.027_bib0150","first-page":"263","article-title":"The Danish National Hospital Register: a valuable source of data for modern health sciences","volume":"46","author":"Andersen","year":"1999","journal-title":"Dan Med Bull"},{"key":"10.1016\/j.eururo.2014.04.027_bib0155","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/CLEP.S17901","article-title":"Existing data sources for clinical epidemiology: the clinical laboratory information system (LABKA) research database at Aarhus University, Denmark","volume":"3","author":"Grann","year":"2011","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.eururo.2014.04.027_bib0160","series-title":"Modern epidemiology","author":"Rothman","year":"2008"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283814004084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283814004084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T14:56:35Z","timestamp":1565448995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283814004084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0302283814004084"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2014.04.027","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformin Use and Prostate Cancer Risk","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2014.04.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}